Dr. Asif Raza Shafiq, DO Neurological Surgery Medicare: Medicare Enrolled Practice Location: 5800 49th St N Ste S201, Saint Petersburg, FL 33709 Phone: 727-605-1770 Fax: 727-605-1080 |
Thomas J Stengel, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 603 7th St S, #540, Saint Petersburg, FL 33701 Phone: 727-553-7550 Fax: 727-553-7549 |
Kirk W Jobe, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 603 7th St S, #540, Saint Petersburg, FL 33701 Phone: 727-553-7550 Fax: 727-553-7549 |
Jonathan S Hall, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 603 7th St S, Suite 500, Saint Petersburg, FL 33701 Phone: 727-893-6667 Fax: 727-528-5942 |
News Archive
University of South Florida professors Selim A. Chacour, David M. Eddy, Dean F. Martin, and G. Douglas Letson have been named 2015 Fellows of the National Academy of Inventors. Chacour and Eddy are in the Institute for Advanced Discovery & Innovation, Martin is in the College of Arts and Sciences and Letson holds appointments at both Moffitt Cancer Center and USF.
The data monitoring committee of the AVERROES study, seeing overwhelming evidence of the success of apixaban in the prevention of stroke in patients with atrial fibrillation who are unsuitable for the conventional treatment of warfarin, has recommended early termination of this study. The decision came after repeated review and careful consideration of all efficacy and safety data.
BioMedix Vascular Solutions, Inc. announced today that John Romans, CEO and Meg Heim, RN, Vice President of Marketing have been invited to participate as members of the P.A.D. Task Force Committee on behalf of the Governor of California, Arnold Schwarzenegger, The California Podiatric Medical Association and the California Department of Chronic Disease and Injury Prevention (CDPH). The committee will meet today, February 4th, 2010 in the California State Capitol, Governors conference room.
A small, retrospective study determined that percutaneous coronary intervention (PCI) was safe in patients with significant coronary artery disease (CAD) who were referred for liver transplantation. Larger studies are needed to determine the effectiveness of angioplasty in patients with end-stage liver disease (ESLD).
› Verified 1 days ago